Humoral immune responses to CTL epitope peptides from tumor-associated antigens are widely detectable in humans: A new biomarker for overall survival of patients with malignant diseases
Authors:
- Satoko MatsuedaSMSatoko Matsueda
- Nobukazu KomatsuNKNobukazu Komatsu
- Kenichi KusumotoKKKenichi Kusumoto
- Shintaro KogaSKShintaro Koga
- Akira YamadaAYAkira Yamada
- Ryoko KuromatsuRKRyoko Kuromatsu
- Shingo YamadaSYShingo Yamada
- Ritsuko SekiRSRitsuko Seki
- Shigeru YutaniSYShigeru Yutani
- Shigeki ShichijoSSShigeki Shichijo
- Takashi MineTMTakashi Mine
- Takaaki FukudaTFTakaaki Fukuda
- 1 September 2013
- journal article
- research article
- Published by Elsevier in Developmental & Comparative Immunology
- Vol. 41 (1) , 68-76
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced CancerNew England Journal of Medicine, 2012
- CIGB-247: A VEGF-based therapeutic vaccine that reduces experimental and spontaneous lung metastasis of C57Bl/6 and BALB/c mouse tumorsVaccine, 2012
- Antibody and Th1-type cell-mediated immune responses in elderly and young adults immunized with the standard or a high dose influenza vaccineVaccine, 2011
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaNew England Journal of Medicine, 2010
- Active Antitumor Immunity Elicited by Vaccine Based on Recombinant Form of Epidermal Growth Factor ReceptorJournal of Immunotherapy, 2005
- New multiplexed flow cytometric assay to measure anti‐peptide antibody: a novel tool for monitoring immune responses to peptides used for immunizationScandinavian Journal of Clinical and Laboratory Investigation, 2004
- Prostate‐specific antigen‐derived epitopes capable of inducing cellular and humoral responses in HLA‐A24+ prostate cancer patientsThe Prostate, 2003
- Identification of a prostate‐specific membrane antigen‐derived peptide capable of eliciting both cellular and humoral immune responses in HLA‐A24+ prostate cancer patientsCancer Science, 2003
- INDUCTION OF TUMOR SPECIFIC CYTOTOXIC T LYMPHOCYTES IN PROSTATE CANCER USING PROSTATIC ACID PHOSPHATASE DERIVED HLA-A2402 BINDING PEPTIDEJournal of Urology, 2001
- Identification of Lck-derived peptides capable of inducing HLA-A2-restricted and tumor-specific CTLs in cancer patients with distant metastasesInternational Journal of Cancer, 2001